Hva er kontinuerlig glukoseovervåking (KGO)?

Continuous glucose monitoring provides a more complete picture of a patient’s glucose levels, compared to what you can obtain from a blood glucose meter (BGM). More frequent access to glucose insights leads to more effective diabetes management, for you and your patients.1,2 

Dexcom G6

Smart devices sold separately†

Watch the video below to learn how the Dexcom G6 CGM System can give patients the power of glucose at a glance. 


The Difference is in the Data

slot 3

Some people with diabetes may struggle to understand how diet and exercise play a role in their treatment, or how to effectively titrate insulin accordingly.


But with continuous glucose readings from Dexcom G6, users can see a complete view of their glucose levels in real time, including historic and current glucose values and rate of glucose change, without requiring action from the user providing users with actionable information, over and above a single BGM reading.

Continuous Insight, Day and Night  

Dexcom G6 helps minimise the guesswork derived from making diabetes treatment decisions based on a BGM reading alone and requires zero fingersticks* or scanning to access glucose data, helping to empower patients to self-manage their diabetes. 

Slot 4 image

Primary CGM Components

The Dexcom G6 CGM System consists of four main components: 



Sensoren innføres enkelt ved å trykke på en knapp. En pasient kan påføre sensoren på egen hånd ved å følge brukerveiledningen. 



Overvåker interstitielle glukosenivåer gjennom en liten ledning som er innført rett under huden, og som sender et signal til senderen (ti dagers levetid). 



Festet oppå sensoren. Sender data trådløst til brukerens kompatible skjermenhet. (3 måneders levetid). 



Lar pasientene se sine glukosedata i sanntid og trenddata. Dexcom G6 lar også pasientene motta en rekke advarsler, blant annet en proaktiv Kritisk lavt snart-alarm, en Kritisk lavt-alarm og andre varsler, på skjermenheten. Dette kan bidra til å advare om høye eller lave glukosenivåer. 

The Benefits of CGM for Insulin-Using Patients  

Proven outcomes support your patients' progress compared with conventional blood glucose management (BGM). 

Redusert hypoglykemi

Redusert hypoglykemi

Det proaktive Kritisk lavt snart-varselet fra Dexcom G6 forbindes med redusert hypoglykemi, uten at det finnes en tilsvarende risiko for hyperglykemi.‡,1 

Redusert HbA1c

Redusert HbA1c

Bruken av Dexcom KGO reduserer HbA1c uansett om man bruker flere daglige injeksjoner(MDI) eller insulinpumpe.

Mer tid innen målområdet

Mer tid innen målområdet

Pasienter som bruker KGO fra Dexcom tilbringer vanligvis mer tid i det optimale glykemiske området enn pasienter som bruker blodsukkermålinger.3,4 

Økt livskvalitet

Økt livskvalitet

Bruk av Dexcom G6 forbedrer livskvalitet og velvære.5,6 

Long-Term CGM use Supports Long-Term Benefits and Outcomes

A three-year, real-world clinical trial—the longest CGM outcome study to date—reiterates the clinical impact of using rt-CGM Systems like Dexcom CGM. Study participants with type 1 diabetes (T1D) using a Dexcom rt-CGM System showed significantly reduced HbA1c levels, increased time in range (3.9-10.00 mmol/L), and decreased time below range (<3.1 mmol/L), independent of the insulin delivery method.2

Rt-CGM supports improved diabetes management for your patients in a way that is both accessible and sustainable. Whether your patients are sitting down for a meal, leading a presentation, or getting ready for bed, they can feel more confident in their daily diabetes treatment decisions that help shape the rest of their lives.

2.1 slot 7

Maximise Your In-Person and Remote Appointments


Optimised data sharing and reporting software, like Dexcom CLARITY, allows healthcare professionals to access and review CGM reports that show patterns, trends, and specific data insights for each patient. 

Learn more about Dexcom CLARITY and how you can incorporate your patients’ CGM data into your practice, whether you consult your patients in-person or via virtual appointment.  

*If your glucose alerts and readings from Dexcom G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. 

†To view a list of compatible smart devices, visit dexcom.com/compatibility. 

‡This predictive alert can be triggered with impending hypoglycaemia (glucose of 3.1 mmol/L or below is predicted to occur within the next 20 minutes). 

§ Register for Dexcom CLARITY at clarity.dexcom.com/professional/registration. 

|| An internet connection is required for patients to send their glucose data to Dexcom CLARITY via a compatible smart device: dexcom.com/compatibility 

¶ Healthcare Professionals will only be able to view a patient’s glucose data if the patient elects to share it with them through Dexcom CLARITY. 

1 Puhr S, et al. Diabetes Technol Ther 2019;21(4):155-8.  

2 Šoupal J, et al. Diabetes Care 2019;43(1):37-43. 

3 Beck, RW, et al. JAMA. 2017;317(4):371-378. 

4 Welsh JB, et al. Diabetes Technol Ther. 2019;21(3):128-132. 

5 Polonsky WH, et al. Diabetes Care 2017 ;40(6): 736-741. 

6 Olafsdottir AF, et al. Diabetes Technol Ther. 2018;20(4):274-284